New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 29, 2016 – Actavis launched an AB-rated generic version of Genentech’s Valcyte (valganciclovir) 50 mg/mL oral solution.
Download PDF
Return to publications
